Puma Biotech (PBYI) Tops Q1 EPS by 24c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. AVGO
3. CDNS
4. META
5. SPY
6. INTC
7. JBLU
8. ANT
9. NVDA
10. AAPL

Go back to Puma Biotech (PBYI) Tops Q1 EPS by 24c

Puma Biotechnology (PBYI) PT Lowered to $87 at Stifel

May 10, 2018 5:09 PM EDT

Stifel lowered its price target on Puma Biotechnology (NASDAQ: PBYI) to $87.00 (from $95.00) while maintaining a Buy rating.

Analyst Alex Schwartz commented, "Yesterday Puma reported 1Q18 numbers that included $66.5 million in revenue and a $24.3 million net loss. Nerlynx revenues of $36.0 million were below our $42.1 million... More

Buy the Puma Biotechnology (PBYI) Dip - Citi

May 10, 2018 12:32 PM EDT

Citi analyst Yigal Nochomovitz came out to defend Puma Biotechnology (NASDAQ: PBYI), saying the sell-off is overdone and to buy the dip.

He said the Possible explanations in order of likelihood 1) Lower apparent demand (NRx / new specialty pharmacy pt adds) in April (~230 / 280) vs. March (~300 / 342), 2)... More